Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer

Prostate cancer is the second cause of cancer-related deaths in men worldwide, and new agents for curing the disease are still needed. In this study, we theoretically and experimentally demonstrated that valeric acid (VA) was a HDAC inhibitor, and anti-cancer efficacy of VA in prostate cancer cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Rui, Yang, Hongxing, Li, Ya, Ling, Changquan, Lu, Lingeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522682/
https://www.ncbi.nlm.nih.gov/pubmed/36175803
http://dx.doi.org/10.1007/s12032-022-01814-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522682/
https://www.ncbi.nlm.nih.gov/pubmed/36175803
http://dx.doi.org/10.1007/s12032-022-01814-9

Ejemplares similares